about
Targeting Tumor-Related Immunosuppression for Cancer ImmunotherapyTraditional chinese medicine in treatment of metabolic syndromeVitamins and type 2 diabetes mellitusImmunomodulatory properties of ES-62, a phosphorylcholine-containing glycoprotein secreted by Acanthocheilonema viteaeModulation of T-cell mediated immunity by dopamine receptor d5The adenosine a2b receptor: its role in inflammationProtein structure based strategies for antigen discovery and vaccine development against malaria and other pathogens.p38 mitogen-activated protein kinase: a critical node linking insulin resistance and cardiovascular diseases in type 2 diabetes mellitus.IL-22 Produced by T helper Cell 22 as a New player in the Pathogenesis of Immune Thrombocytopenia.Metabolic syndrome components in murine models.The genetics of obesity and the metabolic syndrome.Molecular determinants of the cardiometabolic phenotype.Sex-gender differences in diabetes vascular complications and treatment.Advanced glycation endproducts and diabetes. Beyond vascular complications.Classical to current approach for treatment of psoriasis: a review.Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies.Immunopharmacology of the main herbal supplements: a review.Biomarkers of immunity and inflammation for use in nutrition interventions: International Life Sciences Institute European Branch work on selection criteria and interpretation.The immune protective effect of the Mediterranean diet against chronic low-grade inflammatory diseases.The roles of parathyroid hormone and calcitonin in bone remodeling: prospects for novel therapeutics.Viral anti-inflammatory reagents: the potential for treatment of arthritic and vasculitic disorders.Culture supernatants from lactobacillus plantarum induce necrosis on a human promyelocytic leukemia cell line.Tetracyclines and pulmonary inflammation.Possible roles of reg family proteins in pancreatic islet cell growth.Abundance and diversity of GI microbiota rather than IgG4 levels correlate with abdominal inconvenience and gut permeability in consumers claiming food intolerances.Structure and functions of the gut microbiome.A pharmacological primer of biased agonismRole of probiotics and functional foods in health: gut immune stimulation by two probiotic strains and a potential probiotic yoghurt.Isoforms of vitamin E differentially regulate inflammation.Effect of Conjugated Linoleic Acid as a Supplement or Enrichment in Foods on Blood Glucose and Waist Circumference in Humans: A Metaanalysis.Family C 7TM receptor dimerization and activation.Matrix metalloproteinases in cancer metastasis: molecular targets for prostate cancer prevention by green tea polyphenols and grape seed proanthocyanidins.Recent advances on neural tube defects with special reference to Valproic Acid.Selective modulators of PPAR activity as new therapeutic tools in metabolic diseases.Activin receptor-like kinases: structure, function and clinical implications.Role of antioxidants, essential fatty acids, carnitine, vitamins, phytochemicals and trace elements in the treatment of diabetes mellitus and its chronic complications.Roles of type 10 17beta-hydroxysteroid dehydrogenase in intracrinology and metabolism of isoleucine and fatty acids.Targeting type 1 diabetes before and at the clinical onset of disease.Gender and susceptibility to sepsis following trauma.Neuro-immune-endocrine mechanisms during septic shock: role for nitric oxide in vasopressin and oxytocin release.
P1433
Q22305775-1C6603E7-5C8C-41D0-BA76-28350AD3D6CCQ24657961-C718189A-7450-4E72-AFCE-1B9D55DB4559Q27022122-316932F5-A4C7-4EEB-AAEA-68F66080F458Q28256606-949E3215-C3F6-4058-A7E0-28BE768765F4Q28291268-CCCD2EE4-8E7C-4BB9-B1DF-EAF9A2AE223FQ28303755-EE59E16F-1744-4D16-B530-F9AE8A542987Q30367375-08568720-D9BB-4FC7-BCC5-DB00D4F63B05Q30447995-944538EA-8EA8-4266-AD47-42011B17B9DDQ33421582-8D0B67B3-F4C6-4ADC-B5DA-EBC65F106027Q33790395-08B0C8E3-9881-4F25-9BA0-13F1A6346891Q33886816-784F504F-CB02-412C-B39C-16544B6C75C8Q33921392-C592D5C5-AE38-4B3A-8437-7FDDCED32E90Q34124174-ACE41994-5987-4B11-A0F1-9FEB890CEB08Q34176897-1C58003A-0F06-479A-B05A-350ABFBC3EC2Q34215101-FDA9F549-8716-43AF-A4F6-007146471603Q34325478-CE3905FE-BBAB-4956-B4B0-D53523DEB6B4Q34399701-2303A76E-8A36-4BF7-BFA0-3FF300C16736Q34428529-168BEE8E-B50E-47A5-8F3C-8016C82A8D56Q34439857-225EB75E-44C0-4AD2-9FCD-6EE6EAE0613CQ34513147-02FEB4D4-DFA9-4CD4-AB96-BBDD0DC3E062Q34600032-C49C5B91-A588-4045-9CF9-62C4D71C0BFAQ34735814-0C0BA4FA-0462-48C7-8B28-0E69BDAAEF27Q34741670-F2C9DBE2-E291-4FE0-9D7C-408B70366951Q34768350-30E7606D-DF16-4424-BCA1-07CA790B951CQ35087430-07246D9F-6E5E-413B-A4D9-1367297EFD10Q35206574-60CA844A-827D-4ECE-8541-3E2467FBCFF0Q35238406-DB2BA84E-1949-4B1A-B435-92B3F4DCD358Q35526287-1159B520-DA70-4041-860E-EF49ECB59D90Q35734135-15681EA8-EE25-4824-BC5D-D514FC7570C1Q36273717-4A3D46C7-8E98-494D-936B-22F3FB94C7B7Q36447467-4A85AFB0-2558-47B7-A8ED-18C26FD297F7Q36447472-1B0E6564-4DEC-446C-BE01-3053DA3915FFQ36447476-EB471FF4-47CC-4413-8C89-C5E790CEBF1BQ36447480-7A139282-E69C-4619-B0B9-2AD0570B4986Q36447485-401C40C2-56A8-4735-A48E-119D3656828DQ36447491-9A17060C-58D2-4FBA-9352-D3CEA609BBAAQ36447498-4A611D49-304B-4179-9647-02B1B0BDC590Q36447503-B9E90133-1730-4E7C-9596-9082388CB79FQ36513057-594496AE-A2F0-48E3-B59D-8CD2AB2F1FB7Q36513061-BBD93976-5543-47FB-BCF5-6EA1EEB6643E
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Bentham Science Publishers
@nl
wissenschaftliche Fachzeitschrift
@de
name
Endocrine, metabolic & immune disorders drug targets
@ast
Endocrine, metabolic & immune disorders drug targets
@en
Endocrine, metabolic & immune disorders drug targets
@es
Endocrine, metabolic & immune disorders drug targets
@it
Endocrine, metabolic & immune disorders drug targets
@nl
type
label
Endocrine, metabolic & immune disorders drug targets
@ast
Endocrine, metabolic & immune disorders drug targets
@en
Endocrine, metabolic & immune disorders drug targets
@es
Endocrine, metabolic & immune disorders drug targets
@it
Endocrine, metabolic & immune disorders drug targets
@nl
prefLabel
Endocrine, metabolic & immune disorders drug targets
@ast
Endocrine, metabolic & immune disorders drug targets
@en
Endocrine, metabolic & immune disorders drug targets
@es
Endocrine, metabolic & immune disorders drug targets
@it
Endocrine, metabolic & immune disorders drug targets
@nl
P3181
P1055
P1156
4100151707
P1250
P1476
Endocrine, metabolic & immune disorders drug targets
@en